Literature DB >> 6847789

Kinetics and imaging of indium-11-labeled autologous platelets in experimental myocardial infarction.

K H Laws, J A Clanton, V A Starnes, F M Lupinetti, J C Collins, J A Oates, J W Hammon.   

Abstract

The kinetics of accumulation and the external imaging patterns of indium-111-labeled platelets infused in a dog model of left anterior descending coronary artery occlusion with reperfusion were studied. The effects of infarct age and regional residual myocardial blood flow upon platelet accumulation were quantified, and the capacity of indium-111 platelets to image the experimental infarction was evaluated qualitatively. The endocardial accumulation of indium-111 platelets occurred primarily in infarct zones with residual blood flow less than 0.6 times normal and was maximal (24.98 +/- 2.76 times normal) in the lowest blood flow zone (less than 0.1 times normal). Indium-111 platelet accumulation in the epicardium occurred in the regions with blood flow less than 0.6 times normal and was maximal (17.83 +/- 1.20 times normal) in the lowest blood flow zone (less than 0.1 times normal). The maximal endocardial and epicardial platelet accumulation occurred 24 hours after reperfusion and was significantly decreased at 48 hours. In vivo cardiac images revealed discrete areas of increased myocardial radioactivity uptake in the anterior wall of dogs 24 hours after reperfusion. All images 48 hours after reperfusion were negative. Thus, in the experimental setting, indium-111 platelets allow quantification of platelet accumulation after myocardial infarction at a tissue level and provide a noninvasive means of in vivo imaging of reperfused infarcted myocardium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847789     DOI: 10.1161/01.cir.67.1.110

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor.

Authors:  C Weber; T A Springer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.

Authors:  P S Lidbury; R Cirillo; J R Vane
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.

Authors:  Y Kita; T Sugimoto; Y Hirasawa; K Yoshida; K Maeda
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

4.  Platelet depletion in experimental myocardial infarction.

Authors:  S R Jolly; W A Schumacher; S L Kunkel; G D Abrams; J Liddicoat; B R Lucchesi
Journal:  Basic Res Cardiol       Date:  1985 May-Jun       Impact factor: 17.165

Review 5.  Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.

Authors:  Melanie Ziegler; Xiaowei Wang; Karlheinz Peter
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.